TrialHuman vaccines & immunotherapeutics2018

Safety and immunogenicity of a meningococcal B recombinant vaccine when administered with routine vaccines to healthy infants in Taiwan: A phase 3, open-label, randomized study.

Nan-Chang Chiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.